Safety and Tolerability of Egalet-002 in Patients With Moderate-to-Severe Chronic Noncancer Pain
NCT02603705
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
281
Enrollment
INDUSTRY
Sponsor class
Conditions
Moderate-to-severe Chronic Noncancer Pain
Interventions
DRUG:
Oxycodone extended-release
Sponsor
Egalet Ltd